Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radboud J Duintjer Tebbens

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
American Journal of Epidemiology|March 31, 2012
The probability of undetected wild poliovirus circulation after apparent global interruption of transmissionDominika A Kalkowska, Radboud J Duintjer Tebbens, Kimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Evaluation of response scenarios to potential polio outbreaks using mathematical modelsKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch
BMC Infectious Diseases|June 2, 2016
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine useRadboud J Duintjer Tebbens, Lee M Hampton, Kimberly M Thompson
BMC Infectious Diseases|April 11, 2018
Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine useRadboud J Duintjer Tebbens, Lee M Hampton, Kimberly M Thompson
Medgenmed : Medscape General Medicine|January 28, 2004
Policy decision options during the first 5 years following certification of polio eradicationNalinee Sangrujee, Radboud J Duintjer Tebbens, Victor M Cáceres, et al.
Food and Environmental Virology|July 9, 2017
Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance SystemsRadboud J Duintjer Tebbens, Marita Zimmermann, Mark A Pallansch, et al.
Vaccine|May 1, 2010
Optimal vaccine stockpile design for an eradicated disease: application to polioRadboud J Duintjer Tebbens, Mark A Pallansch, James P Alexander, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|October 9, 2018
Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Pakistan and AfghanistanDominika A Kalkowska, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Accident; Analysis and Prevention|November 29, 2023
What do surrogate safety metrics measure? Understanding driving safety as a continuumAmitai Y Bin-Nun, Cristhian Lizarazo, Anthony Panasci, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Global surveillance and the value of information: the case of the global polio laboratory networkEsther de Gourville, Radboud J Duintjer Tebbens, Nalinee Sangrujee, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
American Journal of Epidemiology|March 31, 2012
The probability of undetected wild poliovirus circulation after apparent global interruption of transmissionDominika A Kalkowska, Radboud J Duintjer Tebbens, Kimberly M Thompson
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Evaluation of response scenarios to potential polio outbreaks using mathematical modelsKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch
BMC Infectious Diseases|June 2, 2016
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine useRadboud J Duintjer Tebbens, Lee M Hampton, Kimberly M Thompson
BMC Infectious Diseases|April 11, 2018
Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine useRadboud J Duintjer Tebbens, Lee M Hampton, Kimberly M Thompson
Medgenmed : Medscape General Medicine|January 28, 2004
Policy decision options during the first 5 years following certification of polio eradicationNalinee Sangrujee, Radboud J Duintjer Tebbens, Victor M Cáceres, et al.
Food and Environmental Virology|July 9, 2017
Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance SystemsRadboud J Duintjer Tebbens, Marita Zimmermann, Mark A Pallansch, et al.
Vaccine|May 1, 2010
Optimal vaccine stockpile design for an eradicated disease: application to polioRadboud J Duintjer Tebbens, Mark A Pallansch, James P Alexander, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|October 9, 2018
Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Pakistan and AfghanistanDominika A Kalkowska, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Accident; Analysis and Prevention|November 29, 2023
What do surrogate safety metrics measure? Understanding driving safety as a continuumAmitai Y Bin-Nun, Cristhian Lizarazo, Anthony Panasci, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Global surveillance and the value of information: the case of the global polio laboratory networkEsther de Gourville, Radboud J Duintjer Tebbens, Nalinee Sangrujee, et al.
Pageof 7